Cary Street Partners Investment Advisory’s Merck MRK Stock Holding History
Bought
Maintained
Sold
Other funds holding MRK
Cary Street Partners Investment Advisory's MRK Position: Q2 2026 in Review
Cary Street Partners Investment Advisory increased its Merck (MRK) stake by 16% in Q2 2026, buying an estimated $131K and bringing the position to 8,104 shares worth $1.04M. The position accounts for 0.21% of the portfolio, ranked #112.
Cary Street Partners Investment Advisory first reported a position in MRK in Q4 2019 and has held it in 25 quarters since. The position peaked at $23.7M in Q1 2024. 2,688 funds tracked by Wall St. Rank hold MRK as of Q2 2026.
- Cary Street Partners Investment Advisory held 8,104 shares of Merck worth $1.04M as of Q2 2026.
- Cary Street Partners Investment Advisory bought 1,120 Merck shares in Q2 2026, an estimated $131K.
- Merck made up 0.21% of Cary Street Partners Investment Advisory's portfolio in Q2 2026, its #112 holding.
- Cary Street Partners Investment Advisory first reported a position in Merck in Q4 2019 and has held it in 25 quarters since.
- Cary Street Partners Investment Advisory's Merck position peaked at $23.7M in Q1 2024.
- 2,688 funds tracked by Wall St. Rank held Merck as of Q2 2026.
Based on Cary Street Partners Investment Advisory's 13F filing for Q2 2026, filed 17 Jul 2026.